CN107440036A - A kind of Halth-care composition, its preparation and preparation method for improving memory, improving eyesight - Google Patents
A kind of Halth-care composition, its preparation and preparation method for improving memory, improving eyesight Download PDFInfo
- Publication number
- CN107440036A CN107440036A CN201710740182.XA CN201710740182A CN107440036A CN 107440036 A CN107440036 A CN 107440036A CN 201710740182 A CN201710740182 A CN 201710740182A CN 107440036 A CN107440036 A CN 107440036A
- Authority
- CN
- China
- Prior art keywords
- parts
- improving
- memory
- vitamin
- halth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000004438 eyesight Effects 0.000 title claims abstract description 51
- 239000000203 mixture Substances 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 239000007901 soft capsule Substances 0.000 claims abstract description 36
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 34
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 32
- 239000000284 extract Substances 0.000 claims abstract description 26
- 235000021323 fish oil Nutrition 0.000 claims abstract description 25
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 21
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims abstract description 21
- 244000078534 Vaccinium myrtillus Species 0.000 claims abstract description 21
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 21
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000010931 gold Substances 0.000 claims abstract description 20
- 229910052737 gold Inorganic materials 0.000 claims abstract description 20
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 19
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 19
- 235000011478 zinc gluconate Nutrition 0.000 claims abstract description 18
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims abstract description 17
- 229960003080 taurine Drugs 0.000 claims abstract description 17
- 239000011670 zinc gluconate Substances 0.000 claims abstract description 17
- 229960000306 zinc gluconate Drugs 0.000 claims abstract description 17
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 16
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 16
- 239000011718 vitamin C Substances 0.000 claims abstract description 16
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims abstract description 15
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 15
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims abstract description 15
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 15
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 15
- 239000000463 material Substances 0.000 claims abstract description 15
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 15
- 239000011719 vitamin A Substances 0.000 claims abstract description 15
- 229940045997 vitamin a Drugs 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 239000003292 glue Substances 0.000 claims description 24
- 230000006872 improvement Effects 0.000 claims description 24
- 239000002775 capsule Substances 0.000 claims description 21
- 230000036541 health Effects 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 20
- 241000196324 Embryophyta Species 0.000 claims description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 235000013871 bee wax Nutrition 0.000 claims description 13
- 239000012166 beeswax Substances 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 150000004676 glycans Chemical class 0.000 claims description 8
- 235000011187 glycerol Nutrition 0.000 claims description 8
- 229920001282 polysaccharide Polymers 0.000 claims description 8
- 239000005017 polysaccharide Substances 0.000 claims description 8
- 239000008188 pellet Substances 0.000 claims description 7
- 235000010489 acacia gum Nutrition 0.000 claims description 6
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 108010010803 Gelatin Proteins 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 229920000159 gelatin Polymers 0.000 claims description 5
- 239000008273 gelatin Substances 0.000 claims description 5
- 235000019322 gelatine Nutrition 0.000 claims description 5
- 235000011852 gelatine desserts Nutrition 0.000 claims description 5
- 229920001285 xanthan gum Polymers 0.000 claims description 5
- 244000003416 Asparagus officinalis Species 0.000 claims description 4
- 235000005340 Asparagus officinalis Nutrition 0.000 claims description 4
- 240000006499 Flammulina velutipes Species 0.000 claims description 4
- 235000016640 Flammulina velutipes Nutrition 0.000 claims description 4
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 claims description 3
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 claims description 3
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 claims description 3
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 claims description 3
- 229920002414 procyanidin Polymers 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- 239000004744 fabric Substances 0.000 claims description 2
- 239000011701 zinc Substances 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- NAOLWIGVYRIGTP-UHFFFAOYSA-N 1,3,5-trihydroxyanthracene-9,10-dione Chemical compound C1=CC(O)=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1 NAOLWIGVYRIGTP-UHFFFAOYSA-N 0.000 claims 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 1
- 235000009754 Vitis X bourquina Nutrition 0.000 claims 1
- 235000012333 Vitis X labruscana Nutrition 0.000 claims 1
- 240000006365 Vitis vinifera Species 0.000 claims 1
- 235000014787 Vitis vinifera Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- 239000000047 product Substances 0.000 description 19
- 230000006870 function Effects 0.000 description 10
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 9
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 210000001525 retina Anatomy 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 5
- 238000012549 training Methods 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 4
- 229920001971 elastomer Polymers 0.000 description 4
- 230000006993 memory improvement Effects 0.000 description 4
- RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 description 4
- 235000016357 Mirtillo rosso Nutrition 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 3
- 244000077923 Vaccinium vitis idaea Species 0.000 description 3
- 208000003464 asthenopia Diseases 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- 238000009413 insulation Methods 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 150000008106 phosphatidylserines Chemical class 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- XEHFSYYAGCUKEN-UHFFFAOYSA-N Dihydroscopoletin Natural products C1CC(=O)OC2=C1C=C(OC)C(O)=C2 XEHFSYYAGCUKEN-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000019244 cryptoxanthin Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- FWYIBGHGBOVPNL-UHFFFAOYSA-N scopoletin Natural products COC=1C=C2C=CC(OC2=C(C1)O)=O FWYIBGHGBOVPNL-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- RKUNBYITZUJHSG-FXUDXRNXSA-N (S)-atropine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1 RKUNBYITZUJHSG-FXUDXRNXSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- -1 Carrotene Chemical compound 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 239000004212 Cryptoxanthin Substances 0.000 description 1
- 208000003164 Diplopia Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 229920002752 Konjac Polymers 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 102000004330 Rhodopsin Human genes 0.000 description 1
- 108090000820 Rhodopsin Proteins 0.000 description 1
- 244000275012 Sesbania cannabina Species 0.000 description 1
- 235000000340 Solanum pseudocapsicum Nutrition 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000004482 Withania somnifera Species 0.000 description 1
- 235000001978 Withania somnifera Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical group CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 1
- DMASLKHVQRHNES-FKKUPVFPSA-N beta-cryptoxanthin Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C DMASLKHVQRHNES-FKKUPVFPSA-N 0.000 description 1
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 238000009505 enteric coating Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 229960003210 hyoscyamine Drugs 0.000 description 1
- 229930005342 hyoscyamine Natural products 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229940106134 krill oil Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005056 memory consolidation Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000002464 muscle smooth vascular Anatomy 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000004297 night vision Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 125000001095 phosphatidyl group Chemical group 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000013930 proline Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000006453 vascular barrier function Effects 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- JKQXZKUSFCKOGQ-QAYBQHTQSA-N zeaxanthin Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-QAYBQHTQSA-N 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- 229940050168 zinc lactate Drugs 0.000 description 1
- 235000000193 zinc lactate Nutrition 0.000 description 1
- 239000011576 zinc lactate Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The present invention relates to a kind of Halth-care composition, its preparation and preparation method for improving memory, improving eyesight.The Halth-care composition includes:60~80 parts of refined fish oil; 10~20 parts of phosphatidylserine; 0.5~2 part of gold needle mushroom extract; 0.1~0.5 part of taurine, 1~10 part of matrimony vine, 1~10 part of Bilberry fruit P.E; 0.004~0.006 part of vitamin A; 0.1~0.3 part of vitamin C, 0.05~0.09 part of zinc gluconate, 0~10 part of auxiliary material.The present invention is also provided comprising the preparation for improving the Halth-care composition for remembering, improving eyesight, and the preparation is soft capsule.The present invention also provides the preparation method of the soft capsule.Composition of raw materials Chinese and Western in the present composition combines reasonable compatibility, has an obvious effect to improving eyesight and memory, and soft capsule preparation has the advantages of bioavailability height, be easy to take, be easy to store and carry.
Description
Technical field
The invention belongs to a kind of health products, and in particular to a kind of to have the health products group for improving memory, improving visual function
Compound, its preparation and preparation method.
Background technology
With the development of society, the study of people, operating pressure are also increasing, it is necessary to which knowledge, the information grasped also are got over
Come more, this undoubtedly proposes higher requirement to the memory of people.Also there is report currently for the health products for improving memory
Road.CN105030835A provides a kind of capsule and pill for improving memory, and the content is by following raw material:Squalene 20.000-
30.000%, deep sea fish oil 50.000-60.000%, soybean lecithin 1.000-10.000%, vitamin E 0.100-1%, beeswax
1.000-10.000%, zinc lactate 1.000-10.000%;Bioavailability of the present invention is high, is easy to swallow, is easy to store and takes
The advantages of band, improve memory, anti-aging, the uncomfortable taste of medicine can be covered.Capsule skin is gelatin in this patent,
Gelatin is that the collagenous portion degraded in the connective tissue by animal forms, and has potential virus to carry risk.CN103690627A
A kind of auxiliary improvement of memory healthcare function electuary is disclosed, it is especially a kind of that there is auxiliary improvement of memory healthcare function electuary.Should
The main component of electuary is:Fish oil 1.0g-500g, phosphatidylserine 1-500g, lecithin 1g-500g, walnut 1g-
500g, jujube 1g-500g, taurine 1.2g-2.0g, median chain triglyceride oil 1g-500g, zinc gluconate 0.01g-0.18g.
For the present invention to auxiliary improvement of memory healthcare function, improving depression has remarkable result.Fish oil has fishy smell in this patent, makes electuary
Then need to add a large amount of auxiliary materials to cover, and make the increase of consumer's dose.
In addition, as the improvement of people's living standards, electronic product is popularized very much, computer, TV, flat board, mobile phone
The life of people is flooded with, transition eye has become universal phenomenon, and the activity that outdoor exercises etc. can loosen eyes is got over
Come fewer therefore more and more situations such as caused visual impairment, eyes dry and astringent eye fatigue, people are protected by using health products
The consciousness for protecting eyesight is more and more stronger.CN105030877A discloses a kind of health food for alleviating eye fatigue and its preparation side
Method, the health food can be effectively improved eyesight by lutein, Bilberry fruit P.E, fish oil, krill oil reasonable compatibility, and
And have no toxic side effect.But said composition has no report for the function in terms of improvement memory.
At present, it is simultaneous although for more for the prior art for improving memory and the health products report for improving eyesight
There is not been reported for the health products of tool improvement memory and improvement two kinds of functions of eyesight.
The content of the invention
In view of the shortcomings of the prior art, the present invention provide it is a kind of improve memory, improve eyesight Halth-care composition and its
Preparation method.The existing function of improving memory of the health products, there is the function of improving eyesight again.
The present invention also provides preparation comprising the Halth-care composition and preparation method thereof, and its formulation is soft capsule.
DHA:That is docosahexaenoic acid;
EPA:That is eicosapentaenoic acid.
Bilberry fruit P.E:It with edible ethanol and deionized water is product made of solvent extracts from cowberry to be, main work(
Effect composition is OPC.Market is commercially available.
Gold needle mushroom extract:It is the product extracted with ultrasonic assistant hot water from asparagus, main composition is gold
Pin mushroom polysaccharide, flammulina velutipes are the polymers being formed by connecting by the monose of more than 10 by glycosidic bond.Market is commercially available.
In the present invention, " content " is weight ratio.
Technical scheme is as follows:
A kind of Halth-care composition for improving memory, improving eyesight, parts by weight of raw materials composition include:
60~80 parts of refined fish oil, 10~20 parts of phosphatidylserine, 0.5~2 part of gold needle mushroom extract, taurine 0.1
~0.5 part, 1~10 part of matrimony vine, 1~10 part of Bilberry fruit P.E, 0.004~0.006 part of vitamin A, vitamin C 0.1~0.3
Part, 0.05~0.09 part of zinc gluconate, 0~10 part of auxiliary material.
According to currently preferred, the parts by weight of raw materials composition includes:60~70 parts of refined fish oil, phosphatidylserine
15~20 parts, 0.5~1.5 part of gold needle mushroom extract, 0.2~0.4 part of taurine, 2~8 parts of matrimony vine, 3~9 parts of Bilberry fruit P.E,
0.004~0.005 part of vitamin A, 0.1~0.2 part of vitamin C, 0.06~0.08 part of zinc gluconate, 2~8 parts of auxiliary material.
Most preferably one of scheme of the invention is that the parts by weight of raw materials composition includes:65 parts of refined fish oil, phosphatidyl silk
20 parts of propylhomoserin, 1 part of gold needle mushroom extract, 0.25 part of taurine, 7.75 parts of matrimony vine, 6.75 parts of Bilberry fruit P.E, vitamin
A0.004 parts, 0.15 part of vitamin C, 0.07 part of zinc gluconate, 4 parts of auxiliary material.
According to currently preferred, the refined fish oil is rich in DHA and EPA, wherein DHA content>50%, EPA content>
10%.
According to currently preferred, the matrimony vine is powder of the granularity more than 100 mesh.
According in currently preferred, described Bilberry fruit P.E, procyanidin content is 20~30%.Bilberry fruit P.E
Can market purchase, can also be prepared by prior art.
According in currently preferred, described gold needle mushroom extract, flammulina velutipes content is 30~55%.Asparagus
Extract can market purchase, can also be prepared by prior art.
According to currently preferred, the auxiliary material is beeswax, main to play suspending and make solution uniform.Further preferably
, the auxiliary material beeswax parts by weight are 2~10 parts.
A kind of preparation method for the Halth-care composition for improving memory, improving eyesight, including step:
By proportioning, fish oil and beeswax are mixed, is sufficiently stirred and 30~60min is kept at 60~70 DEG C, then add
Phosphatidylserine, gold needle mushroom extract, taurine, matrimony vine, Bilberry fruit P.E, vitamin A, vitamin C, zinc gluconate,
Stir.
It is a kind of to include the preparation for improving the Halth-care composition for remembering, improving eyesight, it is preferred that the preparation is flexible glue
Capsule.
A kind of health products soft capsule for improving memory, improving eyesight, including capsule shells and the content in capsule shells
Thing, wherein, using Halth-care composition of the present invention as content.Preferably, the capsule shells by plant gum powder, glycerine and
Water forms.Preferably, the parts by weight composition of the capsule shells is 10~40 parts of plant gum powder, 1~20 part of glycerine, water 10~60
Part.Wherein, plant gum powder is the edible rubber powder or/and water solubility cement polysaccharide for coming from plant, such as:Arabic gum, Huang
Virgin rubber, pregelatinized starch, konjaku rubber powder, sesbania gum, pulullan polysaccharide etc..
Preferably, the plant gum powder is made up of pulullan polysaccharide, xanthans and Arabic gum.Further preferably, institute
It is by pulullan polysaccharide to state plant gum powder:Xanthans:Arabic gum is 10 by weight:1~2:1~1.5 mixes.The plant
The good toughness of soft capsule, long-term storage performance are stable made of thing rubber powder.
The improvement memory of the present invention, the preparation method of the health products soft capsule of improvement eyesight, including step:
(1) glue is changed
By proportioning, water and glycerine are well mixed, are heated to 80~100 DEG C, plant gum powder is added and stirs to dissolving completely,
Obtain uniform glue mixture;Filter while hot, be incubated 70~80 DEG C, vacuumize the bubble removal in glue, obtain glue;Protect
Temperature is stood, standby;
(2) content
By proportioning, fish oil and beeswax are mixed, 30~60min is kept at 60~70 DEG C, adds phosphatidylserine, acupuncture needle
Mushroom extract, taurine, matrimony vine, Bilberry fruit P.E, vitamin A, vitamin C, zinc gluconate, stir, and sieving, obtain
Capsule 's content, it is standby.
(3) pelleting
The content of the glue of step (1) and step (2) is pressed into soft capsule with pellet press, 12~18h is dried, produces.
Preferably, step (1) filtering is 80-150 eye mesh screens with screen cloth.Vacuumizing described in step (1) be -
Carried out under 0.08~-0.01MPa vacuum pressures.
Preferably, the Engler viscosity of glue made from step (1) is no more than 16000Pa ﹒ S, using 14000-16000Pa ﹒ S as
Preferably so that enteric coating soft capsule of the present invention rich in toughness, stability is good in long-term storage.The gelatin viscosity is to use grace
What family name's viscosimeter measured at 65 DEG C.
Preferably, the sieving described in step (2) was 80-150 mesh sieves.
Preferably, in step (2), in soft capsule drying process, 20~30 DEG C of holding drying room environment temperature, humidity 20~
40%.
The soft capsule of the present invention, it is 500mg contents/grain that specification, which is made,.It is administered orally, the soft capsule is that enteric solubility is soft
Capsule.
In soft capsule preparation process described above, do not have be particularly limited to by state of the art.
The technical characterstic and beneficial effect of the present invention:
1st, improvement memory of the invention, the Halth-care composition of improvement eyesight, with fish oil, phosphatidylserine, asparagus
Extract, Bilberry fruit P.E and taurine, matrimony vine, vitamin A, vitamin C, zinc gluconate are compounded, and pass through this nine kinds
The synergistic function of component, realize improvement memory while improve the goal of the invention of the Double-function health care product of eyesight.Wherein:
Fish oil is rich in a variety of unrighted acids, and wherein DHA is the part of retina, and supplementing enough DHA can prevent
The only generation of retina thrombus, slow down retinosis, alleviation eyes are dry and astringent, protect eyesight;DHA is also Human Fetal Brain Neuron film
In main lipid components, and the fatty acid composition that brain cell preferential absorption utilizes, to cranial nerve conduction and the life of cynapse
Long hair gives birth to epochmaking effect.Fully fish oil of the supplement rich in DHA can improve the memory of people, be advantageous to improvement again and regard
Power.
Phosphatidylserine mainly improves nerve cell function, adjusts the conduction of nerve impulse, promotes brain memory work(
Can, there is very strong lipophilicity, can enter brain quickly through vascular barrier after absorption, it is thin to play vascular smooth muscle of releiving
Born of the same parents, increase the effect of brain blood supply.
Gold needle mushroom extract can improve the content of protein in cerebral hippocampus tissue, have certain promotion to make to learning and memory
With.
Bilberry fruit P.E can obviously improve night vision, very fast to dark reaction, and eye is exposed to after light, can be very fast extensive
Diplopia is sensitive, can reduce damage of the light to retina, so as to have necessarily pre- to the eye class disease as caused by light injury
Anti- effect.
Taurine is one of free amino acid most abundant in central nervous system, is broken up in the dendron of brain nervous cell
Breed with cell in physiological activity, taurine has obvious facilitation.In addition, taurine be also in retina content it is most rich
One of rich amino acid, there are the multiple functions such as anti-oxidant, film is stable, regulation osmotic pressure.
Matrimony vine, containing LBP-X, again containing glycine betaine (betaine), atropine, hyoscyamine;Separately contain zeaxanthine
(zeaxanthin), wintercherry red pigment (physalein), kryptoxanthin (cryptoxanthin), Scopoletin (scopoletin),
Carrotene, riboflavin, nicotinic acid, vitamin B1, B2 and C, aspartic acid, proline, alanine, leucine etc., there is nourishing liver
Kidney, strengthening the essence blood-nourishing, improving eyesight disappear screen, the effect to moisten the lung and relieve the cough.
Vitamin A has and can produce rhodopsin effect, is the main component of visual pigment in eye retina.
Vitamin C is protect eyes lenticular clearly and prevents the antioxidant of PVR.
Zinc gluconate is the synthesis for participating in liver and retina vitamin A reductase, is the key enzyme of vision thing synthesis,
Other zinc can strengthen the sensitiveness of optic nerve, strengthen light sensation.
Composition of raw materials in the present composition uses Chinese and Western combination principle reasonable compatibility, each component from different aspect, no
Have the function that after each component compounding mutually to cooperate with medical knowledge to eyesight and memory improvement, in composition, synergy.
2nd, a kind of improvement memory, the soft capsule for the Halth-care composition for improving eyesight have bioavailability height, are easy to
The advantages of taking, being easy to store and carry.The present invention is made capsule shells using plant gum powder and can avoid being existed using animal gelatin
Potential virus carry risk.The Engler viscosity for changing the glue obtained after glue is no more than 16000Pa ﹒ S so that enteric of the present invention is soft
Capsule rich in toughness, stability is good in long-term storage.
3rd, composition material of the invention is easy to get, and soft capsule dosage form prepares simple, technical maturity, is easy to production and conversion should
With.
Embodiment
The present invention is described further with reference to embodiment, but not limited to this.
Raw materials used in embodiment is commercial products.Such as:Bilberry fruit P.E, procyanidin content about 25%;Shaanxi
Hong Hao Bioisystech Co., Ltd is on sale.Gold needle mushroom extract, flammulina velutipes content about 40%;The small careless plant science and technology in Xi'an has
It is on sale to limit responsible company.
Pellet press used is the soft capsule pellet press of market purchase in embodiment.The specification of soft capsule is in embodiment
500mg/ grains, wherein 500mg are content.
Plant gum powder used is by pulullan polysaccharide in embodiment:Xanthans:Arabic gum is 10 by weight:1:1 is mixed
Conjunction forms.
Embodiment 1, a kind of Halth-care composition for improving memory, improving eyesight, raw material components are as follows:
Fish oil 65Kg, phosphatidylserine 20Kg, gold needle mushroom extract 1Kg, taurine 0.25Kg, matrimony vine 7.75Kg, more
Tangerine extract 6.75Kg, vitamin A 0.004Kg, vitamin C 0.15Kg, zinc gluconate 0.07Kg, beeswax 4Kg.
A kind of health products soft capsule for improving memory, improving eyesight, using above-mentioned Halth-care composition as content, is pressed
It is prepared by following methods:
(1) 12Kg water and 4Kg glycerine are mixed, is heated to 80~90 DEG C, added 12Kg plant gum powders and stir to complete
Dissolve entirely, obtain uniform glue mixture;After 100 mesh sieve net filtrations, 70~80 DEG C of temperature is true in -0.08~-0.01Mpa
Vacuumized the bubble removal in glue under pneumatics power;Stand, insulation is standby.
(2) 65Kg fish oil and 4Kg beeswaxs are mixed, stirring, 40min are kept at 66 DEG C, add 20Kg phosphatidylserines,
1Kg gold needle mushroom extracts, 0.25Kg taurines, 7.75Kg matrimony vines, 6.75Kg Bilberry fruit P.Es, 0.004Kg vitamin As,
0.15Kg vitamin Cs, 0.07Kg zinc gluconates, are stirred, and are crossed 100 mesh sieves, are obtained capsule 's content, standby.
(3) glue and capsule 's content are pressed into soft capsule with pellet press, keep 20~25 DEG C of drying room environment temperature, wet
18h is dried under the conditions of degree 35~40%, is produced.
Embodiment 2, a kind of Halth-care composition for improving memory, improving eyesight, raw material components are as follows:
Fish oil 70Kg, phosphatidylserine 15Kg, gold needle mushroom extract 1.5Kg, taurine 0.4Kg, matrimony vine 5Kg, cowberry
Extract 8Kg, vitamin A 0.004Kg, vitamin C 0.1Kg, zinc gluconate 0.06Kg, beeswax 3Kg.
A kind of health products soft capsule for improving memory, improving eyesight, using above-mentioned Halth-care composition as content, is pressed
It is prepared by following methods:
(1) 15Kg water and 3Kg glycerine are mixed, is heated to 90~100 DEG C, added 13Kg plant gum powders and stir to complete
Dissolve entirely, obtain uniform glue mixture;After 100 mesh sieve net filtrations, 70~80 DEG C of temperature is true in -0.08~-0.01Mpa
Vacuumized the bubble removal in glue under pneumatics power;Stand, insulation is standby.
(2) 70Kg fish oil and 3Kg beeswaxs are mixed, stirring, 50min are kept at 65 DEG C, add 15Kg phosphatidylserines,
1.5Kg gold needle mushroom extracts, 0.4Kg taurines, 5Kg matrimony vines, 8Kg Bilberry fruit P.Es, 0.004Kg vitamin As, 0.1Kg dimension lifes
Plain C, 0.06Kg zinc gluconate, is stirred, and is crossed 100 mesh sieves, is obtained capsule 's content, standby.
(3) glue and capsule 's content are pressed into soft capsule with pellet press, keep 20~25 DEG C of drying room environment temperature, wet
Under the conditions of degree 30~35%, 15h is dried, is produced.
Embodiment 3, a kind of Halth-care composition for improving memory, improving eyesight, raw material components are as follows:
Fish oil 60Kg, phosphatidylserine 18Kg, gold needle mushroom extract 0.5Kg, taurine 0.3Kg, matrimony vine 7Kg, cowberry
Extract 9Kg, vitamin A 0.005Kg, vitamin C 0.2Kg, zinc gluconate 0.09Kg, beeswax 5Kg.
A kind of health products soft capsule for improving memory, improving eyesight, using above-mentioned Halth-care composition as content, is pressed
It is prepared by following methods:
(1) 10Kg water and 3.5Kg glycerine are mixed, are heated to 90~100 DEG C, add 11Kg plant gum powders stir to
Dissolve completely, obtain uniform glue mixture;After 100 mesh sieve net filtrations, 70~80 DEG C of temperature, in -0.08~-0.01Mpa
Vacuumized the bubble removal in glue under vacuum pressure;Stand, insulation is standby.
(2) 60Kg fish oil and the mixing of 5Kg beeswaxs, stirring, 55min are kept at 62 DEG C, add 18Kg phosphatidylserines,
0.5Kg gold needle mushroom extracts, 0.3Kg taurines, 7Kg matrimony vines, 9Kg Bilberry fruit P.Es, 0.005Kg vitamin As, 0.2Kg dimension lifes
Plain C, 0.09Kg zinc gluconate, is stirred, and is crossed 100 mesh sieves, is obtained capsule 's content, standby.
(3) glue and capsule 's content are pressed into soft capsule with pellet press, keep 20~25 DEG C of drying room environment temperature, wet
12h is dried under the conditions of degree 25~30%, is produced.
Here is zoopery and clinical trial:
1. improve the zoopery of memory
With soft capsule made from embodiment 1, with the 0 of human body recommended amounts, 10,20 and 30 times of setting animal experiment dosage, divide
Not Wei 0.00,0.25,0.50,0.75g/KgBW/d.By 0.2mL/20gBW/d volume gavage mouse, solvent is done with vegetable oil
It is made into respective concentration, control group gavage vegetable oil (same volume).Continuous gavage proceeds by water maze test after 30 days.
Water maze laboratory:Body weight 18-22g female mice, it is randomly divided into 0.00,0.25,0.50 and 0.75g/KgBW/d
One control group and three tested material dosage groups, every group 12.Water maze test is proceeded by after 30 days to tested material.Training period
Between continue to give tested material.Train once daily, continuous 5 days.Mouse is placed near ladder before training in first day, makes its automatic
Climb up 3 times, mouse is placed near ladder before training every time later, it is climbed up automatically 1 time.During training in first day, baffle plate is used
Kept off extremely at A, training is proceeded by from A points;Second day since at B, this distance train 3 days, to 80% animal in 2min
Inside reach terminal;Train from the off within 5th day;(i.e. 5 days arrival ends of each group were finally evaluated with total school grade of 5 days
The number of animals that total time, total errors number and each race of point reach home in two minutes, Memory acquisition and memory consolidation).
Experimental result is as follows:
Table 1, the influence (water maze) obtained to mouse memory
*:Compared with control group, P < 0.05
**:Compared with control group, P < 0.01
(P values are probability, statistically represent a kind of method of the significance of difference, and P < 0.05 are notable, and P < 0.01 are non-
Chang Xianzhu)
As shown in Table 1, through continuously giving the health products 30 days of mouse various dose, Wu Ge dosage groups group mouse is tidied up
The time reached home is considerably less than control group, wherein 0.25,0.50g/KgBW/d dosage groups, compared with control group, difference has aobvious
Work property (P < 0.05);Errors number before each dosage group is reached home is respectively less than control group, and difference has conspicuousness (P <
0.01)。
Water maze test shows that this Halth-care composition plays the role of to improve mouse memory power.
2. improve the clinical trial of eyesight:
General information:100 near-sighted subjects are observed altogether, are randomly divided into test-meal group, control group, each 50.Test-meal group man
Property 30, women 20:It is 13~15 years old age, average 14.56 years old.Control group male 29, women 21:Age 13~15
It is year, average 13.92 years old.
Application method:Test-meal group soft capsule made from the present embodiment 1, orally, 3 times a day, 1 tablet each time;Control group is used
(placebo is the soft capsule one of the soft capsule that content is vegetable oil, its capsule material and outward appearance and embodiment 1 to placebo
Sample), usage amount and the same test-meal group of application method.30 days observing times.
1) ordinary circumstance compares before two groups of observations:
Ordinary circumstance compares (X ± SD) before table 2, observation
Packet | Number of cases | Eye number | The course of disease (year) | Far visual acuity | Diopter |
Test-meal group | 50 | 100 | 1.41±0.07 | 4.43±0.21 | -0.06±0.07 |
Control group | 50 | 100 | 1.43±0.05 | 4.44±0.22 | -0.06±0.08 |
Indices no significant difference (P > 0.05) before two groups of test-meals as shown in Table 2.
2) eyesight change is compared after two groups of test-meals:
The comparison (X ± SD) that distant vision changes after 3, two groups of test-meals of table
Packet | Eye number | Before test-meal | After test-meal | Difference |
Test-meal group | 100 | 4.43±0.21 | 4.72±0.13 | 0.29±0.08** |
Control group | 100 | 4.44±0.23 | 4.44±0.16## | 0.00±0.07## |
* test-meals are front and rear itself to compare:Test-meal group P < 0.01;
Test-meal group is compared with control group after ## test-meals:P < 0.01.
Distant vision variation is notable before and after test-meal group test-meal as shown in Table 3;Compared with control group, test-meal group distant vision becomes
Change significant difference.Illustrate, this Halth-care composition is advantageous to improve distant vision.
3) comparison of vision improvement rate
The comparison of distant vision improvement rate after table 4, test-meal
Packet | Eye number | Effectively | It is invalid | Total effective rate % |
Test-meal group | 100 | 70 | 30 | 70.0 |
Control group | 100 | 7 | 93 | 7.0## |
Test-meal group is compared with control group after ## test-meals:P < 0.01.
As shown in Table 4, compared with control group, the improvement rate of test-meal group distant vision significantly improves.
4) symptom improves situation
Table 5, cardinal symptom improve situation
Control group is indicated in each with (), and symptom improvement rate compares in groups after test-meal:P < 0.01.
As shown in Table 5, compared with control group, the eye of test-meal group is swollen, ophthalmodynia, photophobia, blurred vision, asthenopia, eye are done
Puckery improvement rate significantly improves.
5) symptom integral counts.
Table 6, clinical symptoms integration statistics (X ± SD)
Packet | Number of cases | Before test-meal | After test-meal | Difference |
Test-meal group | 50 | 8.19±2.09 | 4.58±1.59 | 3.61±0.5** |
Control group | 50 | 8.63±1.72 | 7.67±1.75 | 0.96±0.03## |
* test-meals are front and rear itself to compare:Test-meal group P < 0.01;
Test-meal group is compared with control group after ## test-meals:P < 0.01.
As shown in Table 6, significantly reduced after test-meal group test-meal with clinical symptoms before test-meal;Compared with control group, test-meal group
Clinical symptoms significantly reduce.
6) safety indexes are observed:
Security inspection results contrast (X ± SD) before and after table 7, test-meal
As shown in Table 7, before and after test-meal, the general physical examination of two groups of crowds, blood, routine urianlysis result are in normal model
In enclosing.
To the experimental result of eyesight influence, show the health products of the present invention has protective effect to eyes for summary test-meal,
Eyesight can be improved, and do not have adverse reaction during test-meal.
Claims (10)
1. a kind of Halth-care composition for improving memory, improving eyesight, parts by weight of raw materials composition include:
60~80 parts of refined fish oil, 10~20 parts of phosphatidylserine, 0.5~2 part of gold needle mushroom extract, taurine 0.1~0.5
Part, 1~10 part of matrimony vine, 1~10 part of Bilberry fruit P.E, 0.004~0.006 part of vitamin A, 0.1~0.3 part of vitamin C, grape
0.05~0.09 part of saccharic acid zinc, 0~10 part of auxiliary material.
2. the Halth-care composition as claimed in claim 1 for improving memory, improving eyesight, it is characterised in that the raw material weight
Amount part composition includes:60~70 parts of refined fish oil, 15~20 parts of phosphatidylserine, 0.5~1.5 part of gold needle mushroom extract, ox
0.2~0.4 part of sulfonic acid, 2~8 parts of matrimony vine, 3~9 parts of Bilberry fruit P.E, 0.004~0.005 part of vitamin A, vitamin C 0.1~
0.2 part, 0.06~0.08 part of zinc gluconate, 2~8 parts of auxiliary material.
3. the Halth-care composition as claimed in claim 1 for improving memory, improving eyesight, it is characterised in that the raw material weight
Amount part composition includes:65 parts of refined fish oil, 20 parts of phosphatidylserine, 1 part of gold needle mushroom extract, 0.25 part of taurine, matrimony vine
7.75 parts, 6.75 parts of Bilberry fruit P.E, 0.004 part of vitamin A, 0.15 part of vitamin C, 0.07 part of zinc gluconate, auxiliary material 4
Part.
4. improvement memory, the Halth-care composition of improvement eyesight as described in claim any one of 1-3, it is characterised in that institute
State DHA content in refined fish oil>50%, EPA content>10%;Preferably, in described Bilberry fruit P.E, procyanidin content
For 20~30%;Preferably, in described gold needle mushroom extract, flammulina velutipes content is 30~55%.
5. improvement memory, the Halth-care composition of improvement eyesight as described in claim any one of 1-4, it is characterised in that institute
It is beeswax to state auxiliary material.
6. a kind of health products soft capsule for improving memory, improving eyesight, including capsule shells and the content in capsule shells,
Wherein, using the improvement memory described in claim any one of 1-5, the Halth-care composition of improvement eyesight as content.
7. the health products soft capsule as claimed in claim 6 for improving memory, improving eyesight, it is characterised in that the capsule shells
It is made up of plant gum powder, G & W;Preferably, the parts by weight composition of the capsule shells is 10~40 parts of plant gum powder, glycerine 1
~20 parts, 10~60 parts of water.
8. the health products soft capsule as claimed in claim 7 for improving memory, improving eyesight, it is characterised in that the natural plant gum
Powder is made up of pulullan polysaccharide, xanthans and Arabic gum;It is preferred that the plant gum powder is by pulullan polysaccharide:Xanthans:
Arabic gum is 10 by weight:1~2:1~1.5 mixes.
9. the preparation method of the health products soft capsule of improvement memory, improvement eyesight described in claim any one of 6-8, including step
Suddenly:
(1) glue is changed
By proportioning, water and glycerine are well mixed, are heated to 80~100 DEG C, plant gum powder is added and stirs to dissolving completely, obtain
Uniform glue mixture;Filter while hot, be incubated 70~80 DEG C, vacuumize the bubble removal in glue, obtain glue;It is incubated quiet
Put, it is standby;
(2) content
By proportioning, fish oil and beeswax are mixed, 30~60min is kept at 60~70 DEG C, adds phosphatidylserine, asparagus carries
Thing, taurine, matrimony vine, Bilberry fruit P.E, vitamin A, vitamin C, zinc gluconate are taken, is stirred, sieves, obtains capsule
Content, it is standby;
(3) pelleting
The content of the glue of step (1) and step (2) is pressed into soft capsule with pellet press, 12~18h is dried, produces;
Preferably, step (1) filtering is 80-150 eye mesh screens with screen cloth, and vacuumizing described in step (1) is -0.08
Carried out under~-0.01MPa vacuum pressures.
10. the preparation method of the health products soft capsule as claimed in claim 9 for improving memory, improving eyesight, wherein, step
(1) Engler viscosity of glue made from is 14000-16000Pa ﹒ S, and the gelatin viscosity is to use Engler viscometer at 65 DEG C
Measure;Preferably, the sieving described in step (2) was 80-150 mesh sieves;Preferably, in step (2), soft capsule is dried
Cheng Zhong, keep 20~30 DEG C of drying room environment temperature, humidity 20~40%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710740182.XA CN107440036A (en) | 2017-08-25 | 2017-08-25 | A kind of Halth-care composition, its preparation and preparation method for improving memory, improving eyesight |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710740182.XA CN107440036A (en) | 2017-08-25 | 2017-08-25 | A kind of Halth-care composition, its preparation and preparation method for improving memory, improving eyesight |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107440036A true CN107440036A (en) | 2017-12-08 |
Family
ID=60493123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710740182.XA Pending CN107440036A (en) | 2017-08-25 | 2017-08-25 | A kind of Halth-care composition, its preparation and preparation method for improving memory, improving eyesight |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107440036A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108185427A (en) * | 2018-02-11 | 2018-06-22 | 成都图径生物科技有限公司 | Composition for relieving asthenopia containing flake, theanine and phosphatidylserine |
CN109527124A (en) * | 2019-01-24 | 2019-03-29 | 山西潞安石圪节智华生物科技有限公司 | A kind of peony seed oil preparation and preparation method thereof improving memory |
CN109731027A (en) * | 2019-03-08 | 2019-05-10 | 储殷 | Facilitate the composition and preparation method thereof of alleviation visual fatigue and xerophthalmia series symptom |
CN112294837A (en) * | 2020-11-17 | 2021-02-02 | 广州三三医药生物科技有限公司 | Arginine, taurine and glutamine capsule and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102885310A (en) * | 2012-10-19 | 2013-01-23 | 中科乐仁(北京)科技发展有限公司 | Health care food composition capable of assisting in improving memory, and preparation method thereof |
CN104147081A (en) * | 2014-08-20 | 2014-11-19 | 哈尔滨顺亿堂医药生物科技开发有限公司 | Blueberry lutein soft capsule for improving eyesight and manufacturing method thereof |
CN104224890A (en) * | 2014-07-29 | 2014-12-24 | 中宏生物工程有限责任公司 | Lutein soft capsule and preparation method thereof |
CN104840447A (en) * | 2015-06-15 | 2015-08-19 | 湖北人福药用辅料股份有限公司 | Preparation method of pulullan vacant capsules |
CN106692166A (en) * | 2015-11-18 | 2017-05-24 | 珠海宝德润生健康科技有限公司 | Composition with memory improving function, and preparation method thereof |
-
2017
- 2017-08-25 CN CN201710740182.XA patent/CN107440036A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102885310A (en) * | 2012-10-19 | 2013-01-23 | 中科乐仁(北京)科技发展有限公司 | Health care food composition capable of assisting in improving memory, and preparation method thereof |
CN104224890A (en) * | 2014-07-29 | 2014-12-24 | 中宏生物工程有限责任公司 | Lutein soft capsule and preparation method thereof |
CN104147081A (en) * | 2014-08-20 | 2014-11-19 | 哈尔滨顺亿堂医药生物科技开发有限公司 | Blueberry lutein soft capsule for improving eyesight and manufacturing method thereof |
CN104840447A (en) * | 2015-06-15 | 2015-08-19 | 湖北人福药用辅料股份有限公司 | Preparation method of pulullan vacant capsules |
CN106692166A (en) * | 2015-11-18 | 2017-05-24 | 珠海宝德润生健康科技有限公司 | Composition with memory improving function, and preparation method thereof |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108185427A (en) * | 2018-02-11 | 2018-06-22 | 成都图径生物科技有限公司 | Composition for relieving asthenopia containing flake, theanine and phosphatidylserine |
CN109527124A (en) * | 2019-01-24 | 2019-03-29 | 山西潞安石圪节智华生物科技有限公司 | A kind of peony seed oil preparation and preparation method thereof improving memory |
CN109731027A (en) * | 2019-03-08 | 2019-05-10 | 储殷 | Facilitate the composition and preparation method thereof of alleviation visual fatigue and xerophthalmia series symptom |
CN112294837A (en) * | 2020-11-17 | 2021-02-02 | 广州三三医药生物科技有限公司 | Arginine, taurine and glutamine capsule and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108112762B (en) | Novel functional soft sweet and preparation method thereof | |
CN103961469B (en) | Chinese medicine composition and its application, health products and preparation method thereof | |
CN104739921B (en) | A kind of prescription lozenge and preparation method thereof for alleviating visual fatigue | |
CN107440036A (en) | A kind of Halth-care composition, its preparation and preparation method for improving memory, improving eyesight | |
CN108294305A (en) | Alleviation visual fatigue composition containing procyanidine | |
CN102960520B (en) | L-arabinose health-care press candy added with cyclocarya paliurus | |
CN102389115A (en) | Health food for alleviating visual fatigue and preparation method and application thereof | |
CN104432036A (en) | Health care nutrition composition capable of relieving asthenopia as well as preparation method and application thereof | |
CN110169484A (en) | A kind of blueberry lutein ester pressed candy and preparation method thereof | |
CN105707637A (en) | Solid beverage capable of reduce blood glucose, and preparation method thereof | |
CN104957474A (en) | Moringa oleifera composition for reducing blood pressure and preparation method of moringa oleifera composition | |
CN101999649B (en) | Antioxidant health-care product composition and preparation method thereof | |
CN104351782A (en) | Health food for improving anemia | |
CN104397723B (en) | Product for improving immunity and preparation method of product | |
CN101757299A (en) | Product for relieving visual fatigue and preparation method thereof | |
CN100387154C (en) | Health-care food for relieving-vision fatigue and its prepn. method | |
CN105101817B (en) | Edible composition and preparation method thereof and the food comprising said composition | |
CN109619189A (en) | A kind of black fruit Sorbus alnifloria eye protecting milk tablet of sea-buckthorn and preparation method thereof | |
CN101120750B (en) | Method for preparing ginkgo bee product | |
CN109846849A (en) | A kind of masticable nutritional supplement soft capsule and preparation method thereof | |
CN115444134A (en) | Blueberry lutein ester chewable tablet and preparation method thereof | |
CN104957618A (en) | Eye-protecting capsules with dendrobium officinale and fish oil | |
CN108338364A (en) | Composition for relieving asthenopia containing theanine and astaxanthin | |
CN102823686A (en) | Eight-treasure Chinese ixeridium herb tea and preparation method thereof | |
CN102100802B (en) | Chinese medicinal composition for relieving visual fatigue and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171208 |
|
RJ01 | Rejection of invention patent application after publication |